Cencora Raises Fiscal 2026 Adjusted Diluted EPS Outlook to at Least $17.90
Bitget2026/10/21 11:33- Cencora now expects fiscal 2026 adjusted diluted EPS of at least $17.90, versus its previous $17.75-$17.95 range.
- The revised outlook reflects strength in its U.S. Healthcare Solutions segment.
- Its planned American Oncology Network acquisition carries a $2.4 billion enterprise value, including up to $100 million in contingent value rights.
- The acquisition is expected to lift adjusted diluted EPS in the second year following closing.
- Fiscal 2027 expectations will be discussed on the fiscal fourth-quarter 2026 earnings call on November 4, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
2-Yr Benchmark Govt Yields - Germany vs Other Nations
AI demand accelerates and hits production capacity bottleneck! Citi: Storage supply shortage is far from over, maintains high rating on Micron Technology (MU.US) with target price of $1,300
Citi believes that as AI-driven demand from hyperscalers continues to accelerate, the market is underestimating the potential for ongoing tightness in DRAM/HBM supply.
STMicroelectronics (STM.US) Q3 results mixed, guidance exceeds expectations; AI and satellite communication demand support growth
STMicroelectronics (STM.US) released its Q3 2026 financial report and provided guidance for Q4 that surpassed market expectations, indicating a continued recovery in chip demand.
Crypto prices
More
